Impact of sialendoscopy on improving health related quality of life in patients suffering from radioiodine-induced xerostomia

被引:6
作者
Bulut, Olcay Cem [1 ,2 ]
Haufe, Sabine [3 ]
Hohenberger, Ralph [1 ]
Hein, Matti [2 ]
Kratochwil, Clemens [3 ]
Rathke, Hendrik [3 ]
Plinkert, Peter K. [1 ]
Baumann, Ingo [1 ]
Holland-Letz, Tim [4 ]
Haberkorn, Uwe [3 ,5 ]
Flechsig, Paul [3 ]
机构
[1] Univ Hosp Heidelberg, Dept Otorhinolaryngol, INF 400, D-69120 Heidelberg, Germany
[2] SLK Kliniken Klinikum Gesundbrunnen, Dept Otorhinolaryngol, Heilbronn, Germany
[3] Univ Hosp Heidelberg, Dept Nucl Med, Heidelberg, Germany
[4] German Canc Res Ctr, Dept Biostat, Heidelberg, Germany
[5] DKFZ, Clin Cooperat Unit, Dept Nucl Med, Heidelberg, Germany
来源
NUKLEARMEDIZIN-NUCLEAR MEDICINE | 2018年 / 57卷 / 04期
关键词
Sialendoscopy; radioiodine therapy; classification sialendoscopy; health-related quality of life; xerostomia; grading and classification sialadenitis; RADIOACTIVE IODINE THERAPY; DIFFERENTIATED THYROID-CANCER; INDUCED SIALADENITIS; INTERVENTIONAL SIALENDOSCOPY; I-131; THERAPY; NECK-CANCER; DIAGNOSIS; SIALOADENITIS; RADIOTHERAPY; MANAGEMENT;
D O I
10.3413/Nukmed-0964-18-03
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction: Xerostomia following radioiodine therapy (RIT) in patients suffering from differentiated thyroid cancer is a common side effect in 2 % to 67% of patients treated with radioiodine (1-131). In order to evaluate the impact of sialendoscopy on health related quality of life (HRQOL) in patients suffering from therapy induced sialadenitis and xerostomia, we analyzed findings from two dedicated questionnaires (Xerostomy Questionnaire XQ and Xerostomy Inventory XI) in patients before and three months after sialendoscopy. Procedures: In total, 12 patients suffering from differentiated thyroid carcinoma (10 women and 2 men) were evaluated. All patients had experienced conservative management. Patients were offered a sialendoscopy procedure if no major contradictions were present. Patients who denied the procedure formed the control group. Pre- and (three months) postoperative HRQOL was measured with the Patient Reported Outcome Measures (PROM) Xerostomia Questionnaire (XQ) and the Xerostomia Inventory (XI), as well as by a pre- and post-interventional salivary gland scintigram. Patients were graded according to their sialendoscopical findings. Results: Interventional group presented with significant improvements in HRQOL measurements regarding XQ and Xl-scores three months postoperatively. Control group showed no significant changes in the XQ or the XI scores. Number of HIT and cumulative activity of 1-131 did not correlate with higher disease grade in regards to sialendoscopical findings nor did it correlate with higher XQ- and XI scores. Pre- and post-interventional salivary gland scintigram stated that parotid glands are more severely damaged than submandibular glands (SMG), but no significant scintigraphically changes could be detected after sialendoscopy. Conclusion: Sialendoscopy in patients suffering from therapy induced sialadenitis and xerostomia seems to be beneficial when evaluating the impact on HRQOL. Functional parameters measured by salivary gland scintigram did not show significant changes in post-interventional scintigrams.
引用
收藏
页码:160 / 167
页数:8
相关论文
共 26 条
  • [1] ALLWEISS P, 1984, J NUCL MED, V25, P755
  • [2] Sialendoscopy for Patients with Radioiodine-Induced Sialadenitis and Xerostomia
    Bhayani, Mihir K.
    Acharya, Varun
    Kongkiatkamon, Suchada
    Farah, Sally
    Roberts, Dianna B.
    Sterba, Jennifer
    Chambers, Mark S.
    Lai, Stephen Y.
    [J]. THYROID, 2015, 25 (07) : 834 - 838
  • [3] Quantitative salivary gland scintigraphy.
    Bohuslavizki, KH
    Brenner, W
    Klutmann, S
    Tinnemeyer, S
    Werner, JA
    Mester, J
    Clausen, M
    Henze, E
    [J]. LARYNGO-RHINO-OTOLOGIE, 1997, 76 (10) : 614 - 624
  • [4] Interventional Sialendoscopy for Treatment of Radioiodine-Induced Sialadenitis
    Bomeli, Steven R.
    Schaitkin, Barry
    Carrau, Ricardo L.
    Walvekar, Rohan R.
    [J]. LARYNGOSCOPE, 2009, 119 (05) : 864 - 867
  • [5] Interventional sialendoscopy for radioiodine-induced sialadenitis: quo vadis?
    Canzi, P.
    Cacciola, S.
    Capaccio, P.
    Pagella, F.
    Occhini, A.
    Pignataro, L.
    Benazzo, M.
    [J]. ACTA OTORHINOLARYNGOLOGICA ITALICA, 2017, 37 (02) : 155 - 159
  • [6] Sialoendoscopy: a viable treatment for I131 induced sialoadenitis
    De Luca, R.
    Vicidomini, A.
    Trodella, M.
    Tartaro, G.
    Colella, G.
    [J]. BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2014, 52 (07) : 641 - 646
  • [7] DIRUSSO G, 1994, SURGERY, V116, P1024
  • [8] THE LONG-TERM HAZARDS OF THE TREATMENT OF THYROID-CANCER WITH RADIOIODINE
    EDMONDS, CJ
    SMITH, T
    [J]. BRITISH JOURNAL OF RADIOLOGY, 1986, 59 (697) : 45 - 51
  • [9] Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer
    Eisbruch, A
    Kim, HM
    Terrell, JE
    Marsh, LH
    Dawson, LA
    Ship, JA
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (03): : 695 - 704
  • [10] How should we measure and report radiotherapy-induced xerostomia?
    Eisbruch, A
    Rhodus, N
    Rosenthal, D
    Murphy, B
    Rasch, C
    Sonis, S
    Scarantino, C
    Brizel, D
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2003, 13 (03) : 226 - 234